HPV16 E7 and NHE1 Activation in Cancer Transformation
Author Information
Author(s): Rosa A. Cardone, Giovanni Busco, Maria R. Greco, Antonia Bellizzi, Rosita Accardi, Antonella Cafarelli, Stefania Monterisi, Pierluigi Carratù, Valeria Casavola, Angelo Paradiso, Massimo Tommasino, Stephan J. Reshkin
Primary Institution: Department of General and Environmental Physiology, University of Bari, Bari, Italy
Hypothesis
Does HPV16 E7-dependent transformation activate NHE1 through a PKA-RhoA-p38 signaling pathway?
Conclusion
The study reveals that HPV16 E7 transformation activates NHE1 by inhibiting p38 MAPK through a PKA-dependent mechanism involving RhoA.
Supporting Evidence
- HPV16 E7 expression leads to increased cAMP levels in transformed cells.
- Down-regulation of p38 MAPK is a key event in HPV16 E7-induced transformation.
- PKA activity is necessary for the transformation-dependent stimulation of NHE1.
- RhoA phosphorylation at serine 188 is critical for the activation of NHE1 during transformation.
- Transformation by HPV16 E7 enhances cellular alkalinization, which is essential for tumor development.
Takeaway
When a virus called HPV16 changes normal cells, it makes them more alkaline inside, which helps them grow and spread. This happens because of a chain reaction involving some proteins.
Methodology
The study used cell culture, transfections, and various biochemical assays to analyze the signaling pathways involved in HPV16 E7-induced transformation.
Limitations
The study primarily focuses on in vitro models, which may not fully replicate in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website